Triterpenoids and sesquiterpenoids for prostate cancer therapy
| Main Authors: | Shanmugam, M., Arfuso, Frank, Kumar, Alan Prem, Sethi, G. |
|---|---|
| Format: | Book Chapter |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/71157 |
Similar Items
Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)
by: Shanmugam, M., et al.
Published: (2012)
The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)
by: Ko, J., et al.
Published: (2017)
Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)
by: Sethi, G., et al.
Published: (2018)
Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)
by: Sikka, S., et al.
Published: (2012)
Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)
by: Li, F., et al.
Published: (2015)
Possible use of Punica granatum (Pomegranate) in cancer therapy
by: Khwairakpam, A., et al.
Published: (2018)
by: Khwairakpam, A., et al.
Published: (2018)
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways
by: Shanmugam, M., et al.
Published: (2012)
by: Shanmugam, M., et al.
Published: (2012)
Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
by: Shanmugam, M., et al.
Published: (2014)
by: Shanmugam, M., et al.
Published: (2014)
The effects of phenoxodiol on the cell cycle of prostate cancer cell lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)
by: Shanmugam, M., et al.
Published: (2017)
Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)
by: Ko, J., et al.
Published: (2018)
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice
by: Shanmugam, M., et al.
Published: (2011)
by: Shanmugam, M., et al.
Published: (2011)
PPARγ disease gene network and identification of therapeutic targets for prostate cancer
by: Venkatachalam, G., et al.
Published: (2011)
by: Venkatachalam, G., et al.
Published: (2011)
UPM Teaching Hospital' s milestone in prostate cancer therapy
by: The Health, .
Published: (2024)
by: The Health, .
Published: (2024)
Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)
by: Cheong, D., et al.
Published: (2018)
Multifaceted link between cancer and inflammation
by: Sethi, G., et al.
Published: (2012)
by: Sethi, G., et al.
Published: (2012)
Analysis of the intricate relationship between chronic inflammation and cancer
by: Chai, E., et al.
Published: (2015)
by: Chai, E., et al.
Published: (2015)
The isolation and characterization of triterpenoid acids
by: Shahirah, bt. Zulfahri.
Published: (2006)
by: Shahirah, bt. Zulfahri.
Published: (2006)
Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)
by: Chai, E., et al.
Published: (2015)
Cycloartane triterpenoid as an insulin mimicking agent
by: Darnis, Deny Susanti, et al.
Published: (2012)
by: Darnis, Deny Susanti, et al.
Published: (2012)
SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma
by: Sethi, G., et al.
Published: (2017)
by: Sethi, G., et al.
Published: (2017)
Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review
by: Sethi, G., et al.
Published: (2018)
by: Sethi, G., et al.
Published: (2018)
Unveiling the potential of prostate-specific membrane antigen for precision diagnosis and therapy of prostate cancer: a radiopharmaceutical perspective
by: Hassan, Hishar, et al.
Published: (2024)
by: Hassan, Hishar, et al.
Published: (2024)
The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
by: Zhang, J., et al.
Published: (2016)
by: Zhang, J., et al.
Published: (2016)
Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)
by: Min-Wen, J., et al.
Published: (2017)
Chemistry of xanthorrhizol: synthesis of several bisabolane sesquiterpenoids from xanthorrhizol
by: Mohd. Sirat, Hasnah, et al.
Published: (2007)
by: Mohd. Sirat, Hasnah, et al.
Published: (2007)
Chemistry of xanthorrhizol: synthesis of several bisabolane
sesquiterpenoids from xanthorrhizol
by: Sirat, Hasnah, et al.
Published: (2007)
by: Sirat, Hasnah, et al.
Published: (2007)
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
by: Shanmugam, M., et al.
Published: (2015)
by: Shanmugam, M., et al.
Published: (2015)
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
by: Shanmugam, M., et al.
Published: (2011)
by: Shanmugam, M., et al.
Published: (2011)
The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
by: Arora, L., et al.
Published: (2018)
by: Arora, L., et al.
Published: (2018)
Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
by: Zhang, J., et al.
Published: (2017)
by: Zhang, J., et al.
Published: (2017)
Evidence for the Involvement of the Master Transcription Factor NF-?B in Cancer Initiation and Progression.
by: Puar, Y., et al.
Published: (2018)
by: Puar, Y., et al.
Published: (2018)
Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
by: Shanmugam, M., et al.
Published: (2013)
by: Shanmugam, M., et al.
Published: (2013)
Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)
by: Jia, L., et al.
Published: (2016)
Cycloartane triterpenoids acid from Garcinia eugenifolia
by: Jong, Vivien Yi Mian, et al.
Published: (2013)
by: Jong, Vivien Yi Mian, et al.
Published: (2013)
Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)
by: Manu, K., et al.
Published: (2018)
Similar Items
-
Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012) -
The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017) -
Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018) -
Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012) -
Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)